References
- 1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.
- 2. Tanaka T. Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinog. 2009;8:5.
- 3. Touzin NT, Bush KN, Williams CD, Harrison SA. Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2011;4:169-176.
- 4. Tarantino G., Finelli C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?. World J Gastroenterol. 2013;19:3375–3384.
- 5. Williams CD, Stengel J, Asike MI, etal. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124-131.
- 6. Singh SP, Singh A, Pati GK, et al - A Study of Prevalence of Diabetes and Prediabetes in Patients of Non-Alcoholic Fatty Liver Disease and the Impact of Diabetes on Liver Histology in Coastal Eastern India. Journal of Diabetes Mellitus, 2014;4:290-296.
- 7. Wai-Sun Wong V et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut doi:10.1136/gut.2011.237974
- 8. Hwang ST, Cho YK, Park JH, et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol. 2010;25:562-567.
- 9. Braun S, Bitton-Worms K, LeRoith D. The Link between the Metabolic Syndrome and Cancer. Int J Biol Sci. 2011;7:1003-1015.
- 10. Said O. Muhidin, Ahmed A. Magan, Khalid A. Osman, Shareef Syed, and Mohamed H. Ahmed. The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of theMetabolic Syndrome. J Obes. 2012:637538.
- 11. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F. On behalf of the Risk Factors and Life Expectancy Research Group. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev. 2001;10:937-941.
- 12. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin. Liver Dis. 2007;11:37–54.